| Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry AJ Maniotis, R Folberg, A Hess, EA Seftor, LMG Gardner, J Pe'er, ... The American journal of pathology 155 (3), 739-752, 1999 | 2600 | 1999 |
| Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity T Alon, I Hemo, A Itin, J Pe'er, J Stone, E Keshet Nature medicine 1 (10), 1024-1028, 1995 | 2105 | 1995 |
| Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia J Stone, A Itin, T Alon, J Pe'Er, H Gnessin, T Chan-Ling, E Keshet Journal of Neuroscience 15 (7), 4738-4747, 1995 | 1217 | 1995 |
| Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. J Pe'Er, D Shweiki, A Itin, I Hemo, H Gnessin, E Keshet Laboratory investigation; a journal of technical methods and pathology 72 (6 …, 1995 | 581 | 1995 |
| The prognostic value of tumor blood vessel morphology in primary uveal melanoma R Folberg, V Rummelt, R Parys-Van Ginderdeuren, T Hwang, ... Ophthalmology 100 (9), 1389-1398, 1993 | 499 | 1993 |
| Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity. J Stone, T Chan-Ling, J Pe'er, A Itin, H Gnessin, E Keshet Investigative ophthalmology & visual science 37 (2), 290-299, 1996 | 398 | 1996 |
| Vascular endothelial growth factor upregulation in human central retinal vein occlusion J Pe’er, R Folberg, A Itin, H Gnessin, I Hemo, E Keshet Ophthalmology 105 (3), 412-416, 1998 | 369 | 1998 |
| Mechanisms of photoreceptor death and survival in mammalian retina J Stone, J Maslim, K Valter-Kocsi, K Mervin, F Bowers, Y Chu, N Barnett, ... Progress in retinal and eye research 18 (6), 689-735, 1999 | 328 | 1999 |
| Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement JR Smith, JT Rosenbaum, DJ Wilson, ND Doolittle, T Siegal, EA Neuwelt, ... Ophthalmology 109 (9), 1709-1716, 2002 | 313 | 2002 |
| Lacrimal sac tumors MA Stefanyszyn, AA Hidayat, J Jacob, JC Flanagan Ophthalmic Plastic & Reconstructive Surgery 10 (3), 169-184, 1994 | 294 | 1994 |
| The morphologic characteristics of tumor blood vessels as a marker of tumor progression in primary human uveal melanoma: a matched case-control study R Folberg, J Pe'er, LM Gruman, RF Woolson, G Jeng, PR Montague, ... Human pathology 23 (11), 1298-1305, 1992 | 289 | 1992 |
| Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience S Frenkel, K Hendler, T Siegal, E Shalom, J Pe’Er British Journal of Ophthalmology 92 (3), 383-388, 2008 | 286 | 2008 |
| Global retinoblastoma presentation and analysis by national income level ID Fabian, E Abdallah, SU Abdullahi, RA Abdulqader, SA Boubacar, ... JAMA oncology 6 (5), 685-695, 2020 | 264 | 2020 |
| Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy. J Pe'er, R Folberg, A Itin, H Gnessin, I Hemo, E Keshet British journal of ophthalmology 80 (3), 241-245, 1996 | 263 | 1996 |
| Molecular determinants of human uveal melanoma invasion and metastasis EA Seftor, PS Meltzer, DA Kirschmann, J Pe'er, AJ Maniotis, JM Trent, ... Clinical & experimental metastasis 19, 233-246, 2002 | 238 | 2002 |
| Mitomycin C treatment for conjunctival—corneal intraepithelial neoplasia: a multicenter experience J Frucht-Pery, J Sugar, J Baum, JE Sutphin, J Pe’er, H Savir, EJ Holland, ... Ophthalmology 104 (12), 2085-2093, 1997 | 237 | 1997 |
| Nerve growth factor is preformed in and activates human peripheral blood eosinophils A Solomon, L Aloe, J Pe’er, J Frucht-Pery, S Bonini, S Bonini, ... Journal of Allergy and Clinical Immunology 102 (3), 454-460, 1998 | 233 | 1998 |
| Cyclosporine eyedrops for the treatment of severe vernal keratoconjunctivitis D BenEzra, J Pe'er, M Brodsky, E Cohen American journal of ophthalmology 101 (3), 278-282, 1986 | 227 | 1986 |
| New techniques for drug delivery to the posterior eye segment E Eljarrat-Binstock, J Pe’er, AJ Domb Pharmaceutical research 27, 530-543, 2010 | 182 | 2010 |
| Lack of BRAF mutation in primary uveal melanoma Y Cohen, N Goldenberg-Cohen, P Parrella, I Chowers, SL Merbs, J Pe’er, ... Investigative ophthalmology & visual science 44 (7), 2876-2878, 2003 | 158 | 2003 |
